P.V. Tran

1.5k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

P.V. Tran is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, P.V. Tran has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 2 papers in Clinical Psychology. Recurrent topics in P.V. Tran's work include Schizophrenia research and treatment (11 papers), Treatment of Major Depression (9 papers) and Epilepsy research and treatment (2 papers). P.V. Tran is often cited by papers focused on Schizophrenia research and treatment (11 papers), Treatment of Major Depression (9 papers) and Epilepsy research and treatment (2 papers). P.V. Tran collaborates with scholars based in United States, Canada and Germany. P.V. Tran's co-authors include Charles M. Beasley, R. Tamura, Gary D. Tollefson, J. Street, G.D. Tollefson, Janet H. Potvin, Mark Bradshaw, Gerd Geißlinger, Martin S. Angst and Harald Schmidt and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Clinical Pharmacology & Therapeutics.

In The Last Decade

P.V. Tran

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 693 citations Gary D. Tollefson, Charles M. Beasley et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.V. Tran United States	7	938	258	230	174	121	15	1.2k
Heike Hunger Germany	13	1.5k 1.6×	273 1.1×	245 1.1×	282 1.6×	152 1.3×	14	1.9k
W. Rein France	16	1.1k 1.1×	469 1.8×	215 0.9×	199 1.1×	305 2.5×	48	1.5k
Lisa A. Arvanitis United States	14	1.4k 1.5×	377 1.5×	222 1.0×	283 1.6×	323 2.7×	34	1.8k
R. Tamura United States	8	865 0.9×	236 0.9×	203 0.9×	173 1.0×	73 0.6×	30	1.1k
Pierre V. Trân United States	17	1.5k 1.6×	616 2.4×	304 1.3×	297 1.7×	174 1.4×	28	1.9k
J. Street United States	10	1.4k 1.4×	354 1.4×	210 0.9×	278 1.6×	69 0.6×	29	1.6k
G.D. Tollefson United States	17	1.1k 1.2×	455 1.8×	232 1.0×	442 2.5×	153 1.3×	76	1.6k
Anna Eramo United States	20	841 0.9×	185 0.7×	231 1.0×	225 1.3×	166 1.4×	58	1.2k
Mary Anne Dellva United States	16	831 0.9×	236 0.9×	171 0.7×	185 1.1×	74 0.6×	44	1.3k
Jack Hirschowitz United States	22	812 0.9×	164 0.6×	130 0.6×	144 0.8×	272 2.2×	63	1.4k

Countries citing papers authored by P.V. Tran

Since Specialization

Citations

This map shows the geographic impact of P.V. Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.V. Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.V. Tran more than expected).

Fields of papers citing papers by P.V. Tran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.V. Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.V. Tran. The network helps show where P.V. Tran may publish in the future.

Co-authorship network of co-authors of P.V. Tran

This figure shows the co-authorship network connecting the top 25 collaborators of P.V. Tran. A scholar is included among the top collaborators of P.V. Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.V. Tran. P.V. Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Oertel, B., Lisa Felden, P.V. Tran, et al.. (2009). Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia. Clinical Pharmacology & Therapeutics. 87(2). 204–211. 106 indexed citations

Tran, P.V., Bruce R. Basson, John Kennedy, et al.. (1999). The comparative anti-muscarinic-like side effect profiles of olanzapine and risperidone treatment in patients with schizophrenia spectrum psychosis. European Neuropsychopharmacology. 9. 290–291. 6 indexed citations

Tran, P.V., G.D. Tollefson, Scott W. Andersen, Amy J. Kuntz, & S.H. Hamilton. (1998). Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Schizophrenia Research. 29(1-2). 205–205. 10 indexed citations

Tran, P.V., Miro Jakovljević, G.D. Tollefson, et al.. (1998). 363. Olanzapine vs fluphenazine: Treatment of acute schizophrenic symptomatology and anxiety. Biological Psychiatry. 43(8). S109–S109. 7 indexed citations

Tollefson, G.D., Charles M. Beasley, R. Tamura, P.V. Tran, & Janet H. Potvin. (1997). Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. American Journal of Psychiatry. 154(9). 1248–1254. 211 indexed citations

Tollefson, Gary D., et al.. (1997). Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry. 154(4). 457–465. 693 indexed citations breakdown →

Tran, P.V., G.D. Tollefson, S.H. Hamilton, & Amy J. Kuntz. (1997). Olanzapine vs. risperidone in the treatment of psychosis. Biological Psychiatry. 42(1). 178S–179S. 5 indexed citations

Beasley, Charles M., Gary D. Tollefson, & P.V. Tran. (1997). Efficacy of olanzapine: an overview of pivotal clinical trials.. PubMed. 58 Suppl 10. 7–12. 81 indexed citations

Tran, P.V., G.D. Tollefson, Scott W. Andersen, Amy J. Kuntz, & S.H. Hamilton. (1997). P.2.062 Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. European Neuropsychopharmacology. 7. S212–S213. 2 indexed citations

10.

Tran, P.V., et al.. (1996). Long-term continuation therapy with the novel antipsychotic olanzapine: A review of the clinical experience. European Neuropsychopharmacology. 6. S4–115. 6 indexed citations

11.

Dellva, Mary Anne, W. Satterlee, P.V. Tran, et al.. (1996). Extrapyramidal symptoma and tolerability of olanzapine versus haloperidol in acute treatment. European Neuropsychopharmacology. 6. S4–106. 2 indexed citations

12.

Tollefson, G.D., Charles M. Beasley, P.V. Tran, et al.. (1996). Olanzapine versus haloperidol: Results of the multi-center international trial. Schizophrenia Research. 18(2-3). 131–131. 7 indexed citations

13.

Tran, P.V., et al.. (1995). Olanzapine: A promising “atypical” antipsychotic agent. Schizophrenia Research. 15(1-2). 169–169. 5 indexed citations

14.

Tollefson, G.D., et al.. (1994). Olanzapine: A novel antipsychotic with a broad spectrum profile. Biological Psychiatry. 35(9). 746–747. 6 indexed citations

15.

Wood, A. J., Charles M. Beasley, Gary D. Tollefson, & P.V. Tran. (1994). Efficacy of olanzapine in the positive and negative symptoms of schizophrenia. European Neuropsychopharmacology. 4(3). 224–225. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact